Family · Pharmaceutical analytical standards
Idazoxan
A selective antagonist of alpha-2 adrenergic receptors and imidazoline receptors, described in the early 1980s as a potential antidepressant; it did not reach the market and was later studied as an add-on treatment in schizophrenia. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Type I2 imidazoline receptors are defined precisely as the binding sites blocked by idazoxan; the main one is located on the outer membrane of mitochondria.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
